Quarterly results expectations impact? Ahead of Q4 results, Indraprastha Medical Corp share price jumps 8% intraday, hit new 52-week high

Ahead of the quarter four results, Indraprastha Medical Corp shares jumped around eight per cent, touching a new 52-week high to Rs 102.55 per share on the BSE intraday on Wednesday. 

Similarly, the stock has been extending a rally since last five sessions, as it has grown by near 15 per cent and soared around 35 per cent since May 17, 2021. While on a year-to-date basis, the stock has grown almost 80 per cent and surged over 150 per cent in the last year. 

The stock closed at Rs 95.05 per share on Tuesday, down around one per cent. 

The company in its filing to exchanges on June 1, 2021, had said that “the board of directors will hold a meeting on Wednesday, 9th June, 2021, to consider and approve, the audited financial results for the quarter/ year ended 31st March 2021.” 

With a market capitalisation of Rs 918 crore, the company had reported a net profit of Rs 11.99 crore and revenue of Rs 180.01 crore in the December-ended quarter of FY21. And, it is distributed into a 51-49 per cent shareholding pattern between promoters and public, as per the BSE data. 

Indraprastha Apollo Hospitals is a subsidiary of Indraprastha Medical Corp and has entered in the capital market in 1997. It is a multi-specialty 600-bed corporate hospital being set up in New Delhi.  

A joint venture in the healthcare sector between NCT of Delhi and IMCL was the first of its kind in the country, bringing together the strategic focus and operational advantages of the private sector.